Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 7 Neoplasms 6 Neoplasm Metastasis 5 Carcinoma 4 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 NSCLC 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchial Neoplasms 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡